Volume 39, Issue 2, Pages (August 2013)

Slides:



Advertisements
Similar presentations
The Transcription Factor Foxo1 Controls Central-Memory CD8+ T Cell Responses to Infection Myoungjoo V. Kim, Weiming Ouyang, Will Liao, Michael Q. Zhang,
Advertisements

Volume 33, Issue 2, Pages (August 2010)
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Volume 41, Issue 5, Pages (November 2014)
Transforming Growth Factor-β Signaling Curbs Thymic Negative Selection Promoting Regulatory T Cell Development  Weiming Ouyang, Omar Beckett, Qian Ma,
Sustained Interactions between T Cell Receptors and Antigens Promote the Differentiation of CD4+ Memory T Cells  Chulwoo Kim, Theodore Wilson, Kael F.
Volume 40, Issue 1, Pages (January 2014)
Local Inflammatory Cues Regulate Differentiation and Persistence of CD8+ Tissue- Resident Memory T Cells  Tessa Bergsbaken, Michael J. Bevan, Pamela J.
Volume 33, Issue 2, Pages (August 2010)
Initial T Cell Receptor Transgenic Cell Precursor Frequency Dictates Critical Aspects of the CD8+ T Cell Response to Infection  Vladimir P. Badovinac,
Volume 31, Issue 2, Pages (August 2009)
Volume 25, Issue 11, Pages (November 2017)
Volume 13, Issue 6, Pages (November 2015)
Volume 38, Issue 4, Pages (April 2013)
Volume 30, Issue 4, Pages (April 2009)
Volume 39, Issue 5, Pages (November 2013)
Volume 38, Issue 1, Pages (January 2013)
Volume 32, Issue 6, Pages (June 2010)
Volume 33, Issue 2, Pages (August 2010)
Volume 39, Issue 5, Pages (November 2013)
Volume 44, Issue 6, Pages (June 2016)
Protective Capacity of Memory CD8+ T Cells Is Dictated by Antigen Exposure History and Nature of the Infection  Jeffrey C. Nolz, John T. Harty  Immunity 
Volume 34, Issue 1, Pages (January 2011)
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Volume 36, Issue 3, Pages (March 2012)
Volume 37, Issue 4, Pages (October 2012)
Transforming Growth Factor-β Signaling Controls the Formation and Maintenance of Gut-Resident Memory T Cells by Regulating Migration and Retention  Nu.
Volume 27, Issue 1, Pages (July 2007)
Volume 29, Issue 6, Pages (December 2008)
A Mutation in the Nlrp3 Gene Causing Inflammasome Hyperactivation Potentiates Th17 Cell-Dominant Immune Responses  Guangxun Meng, Fuping Zhang, Ivan Fuss,
Volume 42, Issue 2, Pages (February 2015)
Volume 32, Issue 6, Pages (June 2010)
Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses  Axel Kallies, Annie Xin, Gabrielle T.
Volume 40, Issue 5, Pages (May 2014)
Volume 135, Issue 3, Pages (September 2008)
Volume 34, Issue 3, Pages (March 2011)
Volume 42, Issue 1, Pages (January 2015)
Volume 36, Issue 1, Pages (January 2012)
Volume 40, Issue 3, Pages (March 2014)
Volume 29, Issue 1, Pages (July 2008)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 43, Issue 5, Pages (November 2015)
Volume 41, Issue 1, Pages (July 2014)
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
The mTOR Kinase Determines Effector versus Memory CD8+ T Cell Fate by Regulating the Expression of Transcription Factors T-bet and Eomesodermin  Rajesh.
Volume 14, Issue 5, Pages (February 2016)
Cell-Intrinsic IL-27 and gp130 Cytokine Receptor Signaling Regulates Virus-Specific CD4+ T Cell Responses and Viral Control during Chronic Infection 
Volume 30, Issue 6, Pages (June 2009)
Volume 35, Issue 1, Pages (July 2011)
Volume 48, Issue 4, Pages e8 (April 2018)
CD44 Regulates Survival and Memory Development in Th1 Cells
Volume 16, Issue 1, Pages (July 2014)
Volume 27, Issue 2, Pages (August 2007)
Volume 34, Issue 3, Pages (March 2011)
Volume 41, Issue 2, Pages (August 2014)
Volume 30, Issue 4, Pages (April 2009)
Volume 40, Issue 5, Pages (May 2014)
Courtney R. Plumlee, Brian S. Sheridan, Basak B. Cicek, Leo Lefrançois 
Volume 33, Issue 1, Pages (July 2010)
Volume 38, Issue 6, Pages (June 2013)
Volume 35, Issue 4, Pages (October 2011)
Volume 38, Issue 2, Pages (February 2013)
Volume 22, Issue 8, Pages (February 2018)
Volume 40, Issue 3, Pages (March 2014)
Volume 35, Issue 4, Pages (October 2011)
Volume 13, Issue 6, Pages (November 2015)
Volume 30, Issue 5, Pages (May 2009)
Volume 31, Issue 2, Pages (August 2009)
Volume 31, Issue 6, Pages (December 2009)
Volume 35, Issue 1, Pages (July 2011)
Presentation transcript:

Volume 39, Issue 2, Pages 286-297 (August 2013) The Transcription Factor Foxo1 Controls Central-Memory CD8+ T Cell Responses to Infection  Myoungjoo V. Kim, Weiming Ouyang, Will Liao, Michael Q. Zhang, Ming O. Li  Immunity  Volume 39, Issue 2, Pages 286-297 (August 2013) DOI: 10.1016/j.immuni.2013.07.013 Copyright © 2013 Elsevier Inc. Terms and Conditions

Immunity 2013 39, 286-297DOI: (10.1016/j.immuni.2013.07.013) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 Foxo1 Deficiency Does Not Affect Effector CD8+ T Cell Responses to Infection (A–C) WT and GzmB-cre Foxo1fl/fl mice were infected with 5 × 103 cfu of LM-OVA. CD8+ T cell responses were analyzed at day 7 postinfection. (A) The numbers of splenic and liver Kb-ova+ CD8+ T cells in WT and GzmB-cre Foxo1fl/fl mice (n = 4 per genotype). (B) The numbers of splenic and liver IFN-γ+ T cells in WT and GzmB-cre Foxo1fl/fl mice after T cells were restimulated with the SIINFEKL peptide (n = 3 per genotype). (C) CFSE-labeled SIINFEKL-peptide-pulsed target cells and control target cells were mixed at a 1:1 ratio and transferred into WT and GzmB-cre Foxo1fl/fl mice. Four hours posttransfer, the percentages of splenic and liver CFSElo peptide-pulsed target cells were used for calculating antigen-specific killing activity (n = 4–5 per genotype). Data are represented as the mean ± SEM. The p values between the two groups are shown. See also Figures S1 and S2. Immunity 2013 39, 286-297DOI: (10.1016/j.immuni.2013.07.013) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 Foxo1 Is Essential for the Generation of Memory T Cells (A) WT and GzmB-cre Foxo1fl/fl mice were infected with 5 × 103 CFUs of LM-OVA. The frequencies of splenic Kb-ova+ CD8+ T cells at day 60 postinfection are shown. Data are representative of three independent experiments. (B) The numbers of splenic Kb-ova+ CD8+ T cells in WT and GzmB-cre Foxo1fl/fl mice at days 7, 28, and 60 postinfection (n = 4 per genotype). Data are represented as the mean ± SEM. The p values between the two groups of T cells are shown. An asterisk indicates a statistically significant difference. Immunity 2013 39, 286-297DOI: (10.1016/j.immuni.2013.07.013) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3 Foxo1 Deficiency Results in Defective Recall Responses (A–D) WT and GzmB-cre Foxo1fl/fl mice were rechallenged with 1 × 105 cfu of LM-OVA at day 60 postinfection. T cell responses and bacterial burden were determined 3 days after the secondary infection. (A) The numbers of splenic and liver Kb-ova+ CD8+ T cells in WT and GzmB-cre Foxo1fl/fl mice (n = 3 per genotype). Data are representative of three independent experiments. (B) The numbers of splenic and liver IFN-γ+ T cells in WT and GzmB-cre Foxo1fl/fl mice after T cells were restimulated with the SIINFEKL peptide (n = 3 per genotype). (C) CFSE-labeled SIINFEKL-peptide-pulsed target cells and control target cells were mixed at a 1:1 ratio and transferred into WT and GzmB-cre Foxo1fl/fl mice. Four hours later, the percentages of splenic and liver CFSElo peptide-pulsed target cells were used for calculating antigen-specific killing activity (n = 4–6 per genotype). (D) Bacterial burden in the spleens of WT and GzmB-cre Foxo1fl/fl mice (n = 7 per genotype). Data are represented as the mean ± SEM. The p values between the two groups of measurements are shown. An asterisk indicates a statistically significant difference. Immunity 2013 39, 286-297DOI: (10.1016/j.immuni.2013.07.013) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 4 Foxo1 Promotes Memory T Cell Generation through Cell-Intrinsic Mechanisms (A) Bone marrow cells from WT and GzmB-cre Foxo1fl/fl mice were mixed at a 1:1 ratio and transferred into lethally irradiated recipients. The frequencies of Kb-ova+ CD8+ cells originating from WT and GzmB-cre Foxo1fl/fl bone marrow cells at day 60 after LM-OVA infection are shown. Data are representative of two independent experiments (n = 2–3 mice per group). (B) WT OT-I (CD45.1/CD45.1) and GzmB-cre Foxo1fl/fl OT-I (CD45.1/CD45.2) cells were mixed at a 1:1 ratio and transferred into WT recipients (CD45.2/CD45.2). The frequencies of splenic WT OT-I and GzmB-cre Foxo1fl/fl OT-I cells were determined at days 7 and 60 postinfection or at day 7 after the recall response. The ratios of the frequencies of GzmB-cre Foxo1fl/fl OT-I to WT OT-I cells are shown (n = 3–4). Data are represented as the mean ± SEM. Immunity 2013 39, 286-297DOI: (10.1016/j.immuni.2013.07.013) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 5 Reduced MPEC Generation in the Absence of Foxo1 (A) OT-I cells expressing the Foxo1-GFP reporter were transferred to WT recipients. Foxo1-GFP expression in IL-7RαhiKLRG1lo MPECs and IL-7RαloKLRG1hi SLECs at day 7 after LM-OVA infection was determined. CD8+ T cells from WT mice were used as a negative control for GFP expression. (B and C) WT OT-I and GzmB-cre Foxo1fl/fl OT-I cells were mixed at a 1:1 ratio and transferred into WT recipients. (B) Flow cytometric analysis of IL-7Rα and KLRG1 expression in WT OT-I and GzmB-cre Foxo1fl/fl OT-I cells at day 7 postinfection. The frequencies of IL-7RαhiKLRG1lo MPECs are shown. (C) Flow cytometric analysis of CD27 and KLRG1 expression in WT OT-I and GzmB-cre Foxo1fl/fl OT-I cells at day 7 postinfection. The frequencies of CD27hiKLRG1lo MPECs are shown. Data are representative of two independent experiments (n = 2–3 mice per group). Data are represented as the mean ± SEM. The p values between the two groups are shown. An asterisk indicates a statistically significant difference. See also Figures S3–S5 and Table S1. Immunity 2013 39, 286-297DOI: (10.1016/j.immuni.2013.07.013) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 6 Foxo1-Dependent Gene Expression in MPECs (A) Volcano plot of differentially expressed genes between WT CD27hiKLRG1lo OT-I and GzmB-cre Foxo1fl/fl knockout (KO) CD27hiKLRG1lo OT-I cells 7 days postinfection. Data were generated from two independent experiments. Selected Foxo1 target genes are indicated. (B) Differential Il7r, Bcl2, Sell, Ccr7, Tcf7, and Foxo1 expression between WT CD27hiKLRG1lo OT-I and KO CD27hiKLRG1lo OT-I cells 7 days postinfection was confirmed by quantitative PCR. Data were generated from two independent experiments with triplicates for each sample. The different delta cycle thresholds of the two replicates were used for calculating the average values. Data are represented as the mean ± SEM. The p values between the two groups are shown. An asterisk indicates a statistically significant difference. See also Figure S6 and Table S2. Immunity 2013 39, 286-297DOI: (10.1016/j.immuni.2013.07.013) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 7 Ccr7 and Tcf7 Are Foxo1-Bound Target Genes in CD8+ T Cells (A–D) Ccr7 as a putative Foxo1 direct target gene in CD8+ T cells. (A) Foxo1-bound regions in the Ccr7 locus. Arrowheads depict Foxo1 binding detected in both antibody- and biotin-based ChIP-seq experiments. Gene structure, chromosomal location, and sequence homology are shown. (B) Alignment of the conserved Foxo1-binding sites in mouse and human Ccr7 loci. The consensus Foxo1-binding sequences are marked in red. Asterisks show the conserved nucleotides. (C) Foxo1 binding to the ChIP-seq peaks upstream or downstream of Ccr7 (Ccr7-1 or Ccr7-2) was confirmed by ChIP-qPCR. Results are presented relative to enrichment by immunoprecipitation with isotype-matched control antibody. Data are represented as the mean ± SEM. (D) Expression of CCR7 in WT OT-I and GzmB-cre Foxo1fl/fl OT-I cells at day 60 after LM-OVA infection. (E–H) Tcf7 as a putative Foxo1 direct target gene in CD8+ T cells. (E) A Foxo1-bound region in the Tcf7 locus. Arrowhead depicts Foxo1 binding detected in both antibody- and biotin-based ChIP-seq experiments. Gene structure, chromosomal location, and sequence homology are shown. (F) Alignment of the conserved Foxo1-binding sites in mouse and human Tcf7 loci. The consensus Foxo1-binding sequences are marked in red. Asterisks show the conserved nucleotides. (G) Foxo1 binding to the ChIP-seq peak of the Tcf7 promoter region was confirmed by ChIP-qPCR. Results are presented relative to enrichment by immunoprecipitation with isotype-matched control antibody. Data are represented as the mean ± SEM. (H) Expression of TCF-7 in WT OT-I and GzmB-cre Foxo1fl/fl OT-I CD27hiKLRG1lo T cells at day 7 after LM-OVA infection. β-actin was used as a loading control. See also Figure S7. Immunity 2013 39, 286-297DOI: (10.1016/j.immuni.2013.07.013) Copyright © 2013 Elsevier Inc. Terms and Conditions